Smith & Nephew SNATS Inc (SNN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Smith & Nephew SNATS Inc (SNN) has a cash flow conversion efficiency ratio of 0.168x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($888.43 Million) by net assets ($5.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SNN equity financing ratio to measure how much of total assets are equity-financed.
Smith & Nephew SNATS Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Smith & Nephew SNATS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SNN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Smith & Nephew SNATS Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Smith & Nephew SNATS Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GRAB HOLDINGS LTD CL.A
F:A6I
|
0.010x |
|
LTIMindtree Limited
NSE:LTM
|
0.150x |
|
IONQ Inc
NYSE:IONQ
|
-0.030x |
|
COLOPLAST SP.ADR 1/10 DK1
F:CBH
|
0.162x |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
0.061x |
|
Guardant Health Inc
NASDAQ:GH
|
0.362x |
|
Wolters Kluwer N.V.
AS:WKL
|
1.252x |
|
Datang International Power Generation Co Ltd Class A
SHG:601991
|
0.290x |
Annual Cash Flow Conversion Efficiency for Smith & Nephew SNATS Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Smith & Nephew SNATS Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Smith & Nephew SNATS Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.29 Billion | $1.29 Billion | 0.244x | +29.90% |
| 2024-12-31 | $5.26 Billion | $987.00 Million | 0.187x | +60.86% |
| 2023-12-31 | $5.22 Billion | $608.00 Million | 0.117x | +30.96% |
| 2022-12-31 | $5.26 Billion | $468.00 Million | 0.089x | -43.50% |
| 2021-12-31 | $5.57 Billion | $877.00 Million | 0.158x | -11.07% |
| 2020-12-31 | $5.28 Billion | $935.00 Million | 0.177x | -22.04% |
| 2019-12-31 | $5.14 Billion | $1.17 Billion | 0.227x | +18.94% |
| 2018-12-31 | $4.87 Billion | $931.00 Million | 0.191x | -18.62% |
| 2017-12-31 | $4.64 Billion | $1.09 Billion | 0.235x | +9.42% |
| 2016-12-31 | $3.96 Billion | $849.00 Million | 0.215x | -17.41% |
| 2015-12-31 | $3.97 Billion | $1.03 Billion | 0.260x | +53.62% |
| 2014-12-31 | $4.04 Billion | $683.00 Million | 0.169x | -21.09% |
| 2013-12-31 | $4.05 Billion | $867.00 Million | 0.214x | -7.75% |
| 2012-12-31 | $3.88 Billion | $902.00 Million | 0.232x | -12.10% |
| 2011-12-31 | $3.19 Billion | $842.00 Million | 0.264x | -14.71% |
| 2010-12-31 | $2.77 Billion | $859.00 Million | 0.310x | -6.12% |
| 2009-12-31 | $2.18 Billion | $719.00 Million | 0.330x | -0.95% |
| 2008-12-31 | $1.70 Billion | $566.00 Million | 0.333x | +42.68% |
| 2007-12-31 | $1.82 Billion | $424.00 Million | 0.233x | +44.20% |
| 2006-12-31 | $2.17 Billion | $352.00 Million | 0.162x | -10.64% |
| 2005-12-31 | $1.44 Billion | $260.00 Million | 0.181x | -32.84% |
| 2004-12-31 | $1.35 Billion | $363.28 Million | 0.270x | +11.54% |
| 2003-12-31 | $1.14 Billion | $276.79 Million | 0.242x | -17.01% |
| 2002-12-31 | $833.21 Million | $242.85 Million | 0.291x | +18.88% |
| 2001-12-31 | $589.18 Million | $144.46 Million | 0.245x | +120.17% |
| 2000-12-31 | $399.84 Million | $-486.02 Million | -1.216x | -1043.20% |
| 1999-12-31 | $892.49 Million | $115.02 Million | 0.129x | -11.38% |
| 1998-12-31 | $805.88 Million | $117.19 Million | 0.145x | -2.36% |
| 1997-12-31 | $762.58 Million | $113.57 Million | 0.149x | -21.88% |
| 1996-12-31 | $745.62 Million | $142.14 Million | 0.191x | +64.49% |
| 1995-12-31 | $625.35 Million | $72.47 Million | 0.116x | -31.01% |
| 1994-12-31 | $697.12 Million | $117.10 Million | 0.168x | +99.28% |
| 1993-12-31 | $514.17 Million | $43.34 Million | 0.084x | -39.18% |
| 1992-12-31 | $549.35 Million | $76.14 Million | 0.139x | -29.87% |
| 1991-12-31 | $538.71 Million | $106.47 Million | 0.198x | -- |
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more